SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome